Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin for acute uncomplicated cystitis
NCT05702762Phase 2Unknown
- Sponsor
- Mercy
- Start
- Oct 2022
- Primary completion
- Jun 2023
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in urinary tract infection (UTI) comparing Gentamicin Arm with Standard of Care Arm (2 arms). Primary endpoint: Clinical Resolution at 7 days. Status: unknown.
02
Drugs
gentamicin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT05702762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05702762.